Arthrosi Therapeutics, Inc.
6 additional officers and directors
Every relationship, signal and contact on this record, with the source on each.
Includes 3 days of DFX Intelligence. Then $199/month unless canceled.
What matters now
- 9 directorsboard
9 directors on record from Form D filings and board-seat attributions.
The board is who decides on the next round and on a sale.
Facts
- Year of incorporation
- unknown
- Revenue range (Form D)
- Decline to Disclosesec.gov
- Rounds on record
- 2
- Disclosed raised
- unknownsum of rounds with a disclosed amount only
- Named investors
- 0
Financing history
- Jun 6, 2025Form D equity offering · $60.9M (form d sold) · 13 investorsFact Form D · “Arthrosi Therapeutics, Inc. filed Form D: $60,869,972 sold of $153,110,000, Pharmaceuticals”
- Sep 5, 2023Form D equity offering · $7.0M (form d sold) · 1 investorFact Form D · “Arthrosi Therapeutics, Inc. filed Form D: $7,000,000 sold of $75,000,000, Pharmaceuticals”
Investors on record
Ownership and outcomes
How these are wordedA company a buyout or growth firm lists on its own site is “listed in the portfolio of”, never “acquired by”. A date prints only when a deal record gives one; otherwise the row says when DFX first saw it.No firm portfolio page lists this company, so no outcome is stated.
Credit relationships
How a loan is matchedA BDC reports its loans by borrower name. A position shows here only when the match passed a precision gate (a hand-labelled sample was 29 of 30 correct); the tier and confidence are printed on each row. Amounts are the lender’s reported position, never a round.People
- Litain Yeh Executive Officer/Director/Promoter sec.gov
- Shunqi Yan Executive Officer/Director/Promoter sec.gov
- Chaohua Yuan Director Fact
- James Mckay Director Fact
- Xiaojia Cai Director Fact
Timeline
Evidence
Every observation on this company
- Entity type: Corporation Jun 24, 2025 Fact Form D
- Entity type: Corporation Jan 26, 2024 Fact Form D
- Form D industry group: Pharmaceuticals Jun 24, 2025 Fact Form D
- Form D industry group: Pharmaceuticals Jan 26, 2024 Fact Form D
- Amendment: false Jun 24, 2025 Fact Form D
- Amendment: false Jan 26, 2024 Fact Form D
- Revenue range (Form D): Decline to Disclose Jun 24, 2025 Fact Form D
- Revenue range (Form D): Decline to Disclose Jan 26, 2024 Fact Form D
- Incorporated: overFiveYears Jun 24, 2025 Fact Form D
- Incorporated: overFiveYears Jan 26, 2024 Fact Form D
- Jurisdiction: Delaware Jun 24, 2025 Fact Form D
- Jurisdiction: Delaware Jan 26, 2024 Fact Form D
- Amount sold (Form D): $60.9M Jun 24, 2025 Fact Form D
- Amount sold (Form D): $7.0M Jan 26, 2024 Fact Form D
- Offering amount (Form D): $153M Jun 24, 2025 Fact Form D
- Offering amount (Form D): $75.0M Jan 26, 2024 Fact Form D
- Exemptions: 06b Jun 24, 2025 Fact Form D
- Exemptions: 06b Jan 26, 2024 Fact Form D
- First sale: 2025-06-06 Jun 24, 2025 Fact Form D
- First sale: 2023-09-05 Jan 26, 2024 Fact Form D
- Investors (Form D): 13 Jun 24, 2025 Fact Form D
- Investors (Form D): 1 Jan 26, 2024 Fact Form D
- Minimum investment (Form D): 0 Jun 24, 2025 Fact Form D
- Minimum investment (Form D): 0 Jan 26, 2024 Fact Form D
- Securities offered: equity Jun 24, 2025 Fact Form D
- Securities offered: equity Jan 26, 2024 Fact Form D
- Office address: Jun 24, 2025 Fact Form D
- Office address: Jan 26, 2024 Fact Form D
Record history
- Form D filed2025-06-24source on record
- Form D filed2024-01-26source on record
The ledger records every merge, rename and reclassification this record went through and the dated filings observed on it, so the identity on this page can be traced to the records it was built from. The ledger's own sentences name other records, so they show with the names.